​​​
  1. Cipla board approves appointment of Dr Reddy’s Laboratories’ Kedar Upadhye as Global CFO

Cipla board approves appointment of Dr Reddy’s Laboratories’ Kedar Upadhye as Global CFO

Drug firm Cipla today said its board has approved appointment of Kedar Upadhye as the company's Global Chief Financial Officer.

By: | New Delhi | Published: June 8, 2016 5:14 PM
The board of directors today "approved the appointment of Kedar Upadhye as Global Chief Financial Officer of the company who will assume office on or before August 16, 2016," Cipla said in a filing to BSE. The board of directors today “approved the appointment of Kedar Upadhye as Global Chief Financial Officer of the company who will assume office on or before August 16, 2016,” Cipla said in a filing to BSE.

Drug firm Cipla today said its board has approved appointment of Kedar Upadhye as the company’s Global Chief Financial Officer.

The board of directors today “approved the appointment of Kedar Upadhye as Global Chief Financial Officer of the company who will assume office on or before August 16, 2016,” Cipla said in a filing to BSE.

Upadhye will replace Umang Vohra, who will continue to be the Global Chief Operating Officer, it added.

At present, Upadhye is with Dr Reddy’s Laboratories where he is Vice President, Global Generics Finance and Head  of Investor Relations, Cipla said.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Tags: Cipla

Go to Top